Informations sur le produit
Nom :
25,26-Dihydroxyvitamin D3
Synonymes :
- (6R)-2-Methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-1,2-heptanediol
- 1,2-Heptanediol, 2-methyl-6-[(1R,3aS,4E,7aR)-octahydro-4-[(2Z)-2-[(5S)-5-hydroxy-2-methylenecyclohexylidene]ethylidene]-7a-methyl-1H-inden-1-yl]-, (6R)-
- 25,26-Dihydroxycholecalciferol
- 25,26-Dihydroxyvitamin D
- 25,26-Dihydroxyvitamin D<sub>3</sub>
- 29261-12-9
- 9,10-Secocholesta-5,7,10(19)-triene-3,25,26-triol, (3β,5Z,7E)-
- 9,10-Secocholesta-5,7,10(19)-triene-3β,25,26-triol
Description :
25,26-Dihydroxyvitamin D3 is a synthetic product that inhibits the growth of breast cancer cells. This compound is structurally similar to vitamin D3 and has been shown to inhibit the growth of animals with colon cancer. It has also been used in humans to inhibit the growth of breast cancer cells. 25,26-Dihydroxyvitamin D3 inhibits cell proliferation by decreasing the levels of plasma concentrations of hydroxy group and human serum albumin as well as inhibiting protein synthesis in intestinal cells and tubule cells. The effects on these different types of cells may be due to its ability to form isomers with vitamin D3.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
416.64 g/mol
Formule :
C27H44O3
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
